SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    B. Eksteen, Advances and controversies in the pathogenesis and management of primary sclerosing cholangitis, British Medical Bulletin, 2014, 110, 1, 89

    CrossRef

  2. 2
    Matthew J. Hill, Marc P. Forrest, Enca Martin-Rendon, Derek J. Blake, Association of Transcription Factor 4 (TCF4) variants with schizophrenia and intellectual disability, Current Behavioral Neuroscience Reports, 2014, 1, 4, 206

    CrossRef

  3. 3
    Marion J. Pollheimer, Peter Fickert, Bruno Stieger, Chronic cholestatic liver diseases: Clues from histopathology for pathogenesis, Molecular Aspects of Medicine, 2014, 37, 35

    CrossRef

  4. 4
    C. Rupp, K. Friedrich, T. Folseraas, A. Wannhoff, K. A. Bode, K.-H. Weiss, P. Schirmacher, P. Sauer, W. Stremmel, D. N. Gotthardt, Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis, Alimentary Pharmacology & Therapeutics, 2014, 39, 8
  5. 5
    Trine Folseraas, Evaggelia Liaskou, Carl. A. Anderson, Tom H. Karlsen, Genetics in PSC: What Do the “Risk Genes” Teach Us?, Clinical Reviews in Allergy & Immunology, 2014,

    CrossRef

  6. 6
    Evaggelia Liaskou, Gideon M. Hirschfield, M. Eric Gershwin, Mechanisms of tissue injury in autoimmune liver diseases, Seminars in Immunopathology, 2014, 36, 5, 553

    CrossRef

  7. 7
    Kerem Sebib Korkmaz, Bert-Jan F. Rooij, Bart Hoek, Marcel Janse, Minneke J. Coenraad, Johan J. Reijden, Rinse K. Weersma, Robert J. Porte, Philip W. Voorneveld, Andrzej G. Baranski, Hein W. Verspaget, MMP-2 is a disease-modifying gene in primary sclerosing cholangitis, Liver International, 2014, 34, 2
  8. 8
    C. Rupp, A. Rössler, E. Halibasic, P. Sauer, K.-H. Weiss, K. Friedrich, A. Wannhoff, A. Stiehl, W. Stremmel, M. Trauner, D. N. Gotthardt, Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis, Alimentary Pharmacology & Therapeutics, 2014, 40, 11-12
  9. 9
    Christian Rupp, Konrad Bode, Fadi Chahoud, Andreas Wannhoff, Kilian Friedrich, Karl-Heinz Weiss, Peter Sauer, Wolfgang Stremmel, Daniel Gotthardt, Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis, BMC Infectious Diseases, 2014, 14, 1, 562

    CrossRef

  10. 10
    Vincent Zimmer, Frank Lammert, Role of genetics in diagnosis and therapy of acquired liver disease, Molecular Aspects of Medicine, 2014, 37, 15

    CrossRef

  11. 11
    Christina Backes, Frank Rühle, Monika Stoll, Jan Haas, Karen Frese, Andre Franke, Wolfgang Lieb, H-Erich Wichmann, Tanja Weis, Wanda Kloos, Hans-Peter Lenhof, Eckart Meese, Hugo Katus, Benjamin Meder, Andreas Keller, Systematic permutation testing in GWAS pathway analyses: identification of genetic networks in dilated cardiomyopathy and ulcerative colitis, BMC Genomics, 2014, 15, 1, 622

    CrossRef

  12. 12
    Marc P. Forrest, Matthew J. Hill, Andrew J. Quantock, Enca Martin-Rendon, Derek J. Blake, The emerging roles of TCF4 in disease and development, Trends in Molecular Medicine, 2014, 20, 6, 322

    CrossRef

  13. 13
    Eva K.K. Henriksen, Espen Melum, Tom H. Karlsen, Update on primary sclerosing cholangitis genetics, Current Opinion in Gastroenterology, 2014, 30, 3, 310

    CrossRef

  14. 14
    V. Tang, J.R. Friedman, Pathobiology of Human Disease, 2014,

    CrossRef

  15. 15
    George F. Mells, Arthur Kaser, Tom H. Karlsen, Novel insights into autoimmune liver diseases provided by genome-wide association studies, Journal of Autoimmunity, 2013, 46, 41

    CrossRef

  16. 16
    Tom H. Karlsen, Kirsten Muri Boberg, Update on primary sclerosing cholangitis, Journal of Hepatology, 2013, 59, 3, 571

    CrossRef